Skip to content

Clinical trials

Phase 3 Non-alcoholic Fatty Liver Disease trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Phase: Phase 3 Country / region: Poland Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20151
20174
20191
20201
20212
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated5
Recruiting4
Active, not recruiting3
Completed2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.2
Gilead Sciences2
Intercept Pharmaceuticals2
Abbott1
Akero Therapeutics, Inc1
Eli Lilly and Company1
GlaxoSmithKline1
Inventiva Pharma1
Madrigal Pharmaceuticals, Inc.1
Medical University of Lodz1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease15
Fatty Liver4
Liver Diseases4
Fibrosis3
Digestive System Diseases2
Metabolic Diseases2
Acquired Immunodeficiency Syndrome1
Anxiety Disorders1
Depressive Disorder1
HIV Infections1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.